Acumen Hypotension Prediction Index (HPI) Feature Software vs vascuCAP
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Acumen HPI, is designed for real-time prediction and management of acute hypotensive events in critical care settings, utilizing hemodynamic monitoring data. Conversely, Tool B, vascuCAP, focuses on AI-enabled analysis of CT angiography images to quantify plaque composition and assess long-term cardiovascular risk. While both fall under Cardiology AI, they address distinct clinical problems and leverage different data modalities, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Acumen HPI is a predictive monitoring tool designed to detect and alert clinicians to the likelihood of a hypotensive event up to 15 minutes before it occurs, aiding in proactive hemodynamic management. vascuCAP (now ElucidVivo/PlaqueIQ) is an AI software for non-invasive CT angiography analysis, quantifying plaque composition and assessing cardiovascular risk to optimize treatment decisions for conditions like stroke and heart attack.
Acumen HPI uses machine learning algorithms to analyze blood pressure waveforms, compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. vascuCAP analyzes non-invasive CT angiography images to characterize plaque tissues.
Acumen HPI is primarily for Anesthesiology, Critical Care, and Emergency Medicine. vascuCAP is designed for Cardiology, Radiology, and Vascular Surgery.
Acumen HPI is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform. vascuCAP offers both cloud and on-premise deployment options, with DICOM integration and PACS/EMR interoperability.
Acumen HPI provides a Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts, and a Relationship View screen offering insights into preload, afterload, and contractility. vascuCAP quantifies histologically-validated plaque composition, including lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, along with 3D visualization of arterial vessels and plaque.
Acumen HPI has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. vascuCAP supports personalized treatment decisions and risk stratification for stroke and heart attack based on plaque characteristics.